Log in to save to my catalogue

Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature

Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8508132

Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature

About this item

Full title

Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature

Publisher

Basel: MDPI AG

Journal title

International journal of molecular sciences, 2021-09, Vol.22 (19), p.10198

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

The reason behind the high inter-individual variability in response to SARS-CoV-2 infection and patient’s outcome is poorly understood. The present study targets the sphingolipid profile of twenty-four healthy controls and fifty-nine COVID-19 patients with different disease severity. Sera were analyzed by untargeted and targeted mass spectrometry a...

Alternative Titles

Full title

Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8508132

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8508132

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms221910198

How to access this item